StonvexLoading…
StonvexStonvexStonvexCore line items from TLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-05-17 |
|---|---|---|---|---|
Revenue | $2.52B | $1.57B | $1.17B | $478.00M |
Operating Income | $-90.00M | $226.00M | $160.00M | $-76.00M |
Net Income | $-219.00M | $998.00M | $134.00M | $479.00M |
EPS (Diluted) | $-4.79 | $17.67 | $2.26 | Not available |
Total Assets | $10.90B | $6.11B | $7.12B | $7.06B |
Total Liabilities | $9.81B | $4.72B | $4.59B | $4.63B |
Cash & Equivalents | $689.00M | $328.00M | $400.00M | $169.00M |
Free Cash Flow OCF − CapEx | $606.00M | $171.00M | $286.00M | $324.00M |
Shares Outstanding | 45.69M | 45.96M | 59.03M | 59.03M |